Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Materials Science and Engineering: C, 8(32), p. 2418-2425, 2012

DOI: 10.1016/j.msec.2012.07.016

Links

Tools

Export citation

Search in Google Scholar

Nanostructured β-phase Ti–31.0Fe–9.0Sn and sub-μm structured Ti–39.3Nb–13.3Zr–10.7Ta alloys for biomedical applications: Microstructure benefits on the mechanical and corrosion performances

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Nanostructured Ti–31.0Fe–9.0Sn and sub-micrometer structured Ti–39.3Nb–13.3Zr–10.7Ta (wt.%) β-type alloys, exhibiting different microstructures and dissimilar mechanical properties, have been prepared by copper mold casting. The microstructure, mechanical behavior and corrosion resistance, in simulated body fluid, of both alloys have been investigated and compared to those of commercial Ti–6Al–4V. Nanoindentation experiments reveal that the Ti–31.0Fe–9.0Sn rods exhibit very large hardness (H ≈ 9 GPa) and high Young's modulus. Conversely, the Ti–39.3Nb–13.3Zr–10.7Ta alloy is mechanically softer but it is interesting for biomedical application because of its rather low Young's modulus (E ≈ 71 GPa). Concerning the corrosion performance, Ti–35Nb–7Zr–5Ta shows a corrosion behavior comparable to Ti–Al6–V4, with no potential breakdown up to 0.4 V vs. Ag|AgCl. On the contrary, the Ti–31.0Fe–9.0Sn alloy exhibits a more anodic corrosion potential, but the value is still less negative than for pure elemental Fe and Ti. From all these properties and because of the absence of toxic elements in the compositions, the Ti–39.3Nb–13.3Zr–10.7Ta and Ti–31.0Fe–9.0Sn alloys are attractive for use as metallic biomaterials.